Skip to main content
Nathan D. Hatton
( out of 38 reviews )

Nathan D. Hatton, MD

Languages spoken: English

Clinical Locations

Sugar House Health Center

Salt Lake City
801-581-2000

University of Utah Hospital

Cardiovascular Center
Salt Lake City
801-585-7676
  • Nathan D. Hatton, M.D. is a Professor of Medicine at the University of Utah School Of Medicine. He grew up in a small Indiana community before completing his undergraduate education at Hanover College. He subsequently attended Indiana University where he obtained a masters degree in physiology and biophysics prior to attending medical school. He received his medical degree from Indiana University prior to moving to Utah for his training in Internal Medicine at University Of Utah. He completed a Pulmonary Medicine and Critical Care Medicine fellowship at the University of Utah. Upon completion of his fellowship he joined the faculty at the University of Utah in 2009.

    He served as the Associate Medical Director of the Medical Intensive Care Unit at the University Hospital from 2012 to 2017. His current hospital based responsibilities include attending in the Medical Intensive Care Unit at University Hospital and focusing on housestaff and nursing education. His outpatient clinical care focuses on general pulmonary diseases along with patients with pulmonary hypertension. He is the co-director of the Pulmonary Hypertension Dyspnea Center at the University of Utah. He also has directed the second year medical student pulmonary medicine curriculum for the past decade. He has recently been promoted to the pulmonary core educator with in the University of Utah Medical school overseeing the entire four year pulmonary curriculum. Most recently, he has been an intricate part in the planning and management of the SARS-2-CoV pandemic at the University of Utah hospital. For this project, he has applied continuous critical care experience taking care of COVID19 patients since March 2020 to assist in study design. His experiences are most helpful in assessing key clinical annotations that may be helpful in understanding the plausibility of different biological pathways that underlie our deep clinical experience. For example, to consider how the different SARS-CoV-2 variants affect specific findings related to respiratory failure which may be plausible modifiers of biological pathways that underlie poor outcomes. Of course, he overseeing the collection of simultaneous upper airway and tracheal samples to enable the multiple laboratory measurements that make this project novel, compelling and generalizable.

    Board Certification

    American Board of Internal Medicine (Sub: Critical Care Medicine)
    American Board of Internal Medicine (Sub: Pulmonary Disease)

    Patient Rating

    5.0 /5
    ( out of 38 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    April 30, 2024
    SUGAR HOUSE HEALTH CENTER

    I trust & believe in his care for me-He listens & very supportive-he¿s one of the reasons why I¿m doing so well!

    April 23, 2024
    SUGAR HOUSE HEALTH CENTER

    Thank you so much for taking the time to understand my health journey and explaining so much to me. I appreciated more than you know

    March 30, 2024
    SUGAR HOUSE HEALTH CENTER

    He prepared & never in a hurry- his kindness & professionalism are outstanding-

    March 16, 2024
    SUGAR HOUSE HEALTH CENTER

    I absolutely love Dr hatton! I've never had a doctor who cares so deeply and also has a awesome sence of humor! Haha I'd tell anyone 100% to go to him. And I am super lucky to have him on my care team!

    March 12, 2024
    SUGAR HOUSE HEALTH CENTER

    Dr Hatton is incredible! He spends the most amount of time with me of all my doctors. He really checks in on how I am doing and is extremely patient in answering all of my questions and helping me understand.

    March 12, 2024
    SUGAR HOUSE HEALTH CENTER

    As always he was very caring but he seemed sad today

    March 01, 2024
    SUGAR HOUSE HEALTH CENTER

    Very smart and caring

    February 06, 2024
    SUGAR HOUSE HEALTH CENTER

    Dr Hatton is a very caring about the patient's care. I would recommend him highly to anyone looking for a capable cardiologist.

    December 23, 2023
    SUGAR HOUSE HEALTH CENTER

    Dr Hatton was polite & courteous. Would recommend to others for the same medical issues I have. Thank you.

  • Nathan D. Hatton, M.D. is a Professor of Medicine at the University of Utah School Of Medicine. He grew up in a small Indiana community before completing his undergraduate education at Hanover College. He subsequently attended Indiana University where he obtained a masters degree in physiology and biophysics prior to attending medical school. He received his medical degree from Indiana University prior to moving to Utah for his training in Internal Medicine at University Of Utah. He completed a Pulmonary Medicine and Critical Care Medicine fellowship at the University of Utah. Upon completion of his fellowship he joined the faculty at the University of Utah in 2009.

    He served as the Associate Medical Director of the Medical Intensive Care Unit at the University Hospital from 2012 to 2017. His current hospital based responsibilities include attending in the Medical Intensive Care Unit at University Hospital and focusing on housestaff and nursing education. His outpatient clinical care focuses on general pulmonary diseases along with patients with pulmonary hypertension. He is the co-director of the Pulmonary Hypertension Dyspnea Center at the University of Utah. He also has directed the second year medical student pulmonary medicine curriculum for the past decade. He has recently been promoted to the pulmonary core educator with in the University of Utah Medical school overseeing the entire four year pulmonary curriculum. Most recently, he has been an intricate part in the planning and management of the SARS-2-CoV pandemic at the University of Utah hospital. For this project, he has applied continuous critical care experience taking care of COVID19 patients since March 2020 to assist in study design. His experiences are most helpful in assessing key clinical annotations that may be helpful in understanding the plausibility of different biological pathways that underlie our deep clinical experience. For example, to consider how the different SARS-CoV-2 variants affect specific findings related to respiratory failure which may be plausible modifiers of biological pathways that underlie poor outcomes. Of course, he overseeing the collection of simultaneous upper airway and tracheal samples to enable the multiple laboratory measurements that make this project novel, compelling and generalizable.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Academic Divisions Public Health
    Board Certification
    American Board of Internal Medicine (Sub: Critical Care Medicine)
    American Board of Internal Medicine (Sub: Pulmonary Disease)

    Education history

    Fellowship Pulmonary/Critical Care - University of Utah School of Medicine Fellow
    Internal Medicine - University of Utah School of Medicine Resident
    Internship Internal Medicine - University of Utah School of Medicine Intern
    Medicine - Indiana University School of Medicine M.D.
    Graduate Training Physiology - Indiana University M.A.
    Biology - Hanover College B.A.

    Selected Publications

    Journal Article

    1. Ingram D, Alamri AK, Penn BA, Mayeux JD, Ma CL, Clapham KR, Abraham AE, Klanderud D, Sadeh B, Beck EM, Hatton ND, Ryan JJ (2022). Characteristics of Patients With Pulmonary Arterial Hypertension in a Pulmonary Hypertension Association-Accredited Comprehensive Care Center: A Contrast in Features When Compared With US National Registry Data. Cureus, 14(11), e31764. (Read full article)
    2. Tonna JE, Pierce J, Hatton N, Lewis G, Phillips JD, Messina A, Skidmore CR, Taylor K, Selzman CH (2021). Safety and feasibility of using acellular sterile filtered amniotic fluid as a treatment for patients with COVID-19: protocol for a randomised, double-blinded, placebo-controlled clinical trial. BMJ Open, 11(2), e045162. (Read full article)
    3. Selzman CH, Tonna JE, Pierce J, Vargas C, Skidmore C, Lewis G, Hatton ND, Phillips JD (2021). A pilot trial of human amniotic fluid for the treatment of COVID-19. BMC Res Notes, 14(1), 32. (Read full article)
    4. Mayeux JD, Pan IZ, Dechand J, Jacobs JA, Jones TL, McKellar SH, Beck E, Hatton ND, Ryan JJ (2020). Management of Pulmonary Arterial Hypertension. Curr Cardiovasc Risk Rep, 15(1), 2. (Read full article)
    5. Ciarkowski CE, Timbrook TT, Kukhareva PV, Edholm KM, Hatton ND, Hopkins CL, Thomas F, Sanford MN, Igumnova E, Benefield RJ, Kawamoto K, Spivak ES (2020). A Pathway for Community-Acquired Pneumonia With Rapid Conversion to Oral Therapy Improves Health Care Value. Open Forum Infect Dis, 7(11), ofaa497. (Read full article)
    6. Edholm K, Lapp K, Kukhareva P, Hopkins C, Hatton ND, Gebhart B, Nyman H, Signor E, Davis M, Kawamoto K, Johnson SA (2020). Reducing Diabetic Ketoacidosis Intensive Care Unit Admissions Through an Electronic Health Record-Driven, Standardized Care Pathway. J Healthc Qual, 42(5), e66-e74. (Read full article)
    7. Jin N, Hatton N, Swartz DR, Xia Xl, Harrington MA, Larsen SH, Rhoades RA (2000). Hypoxia activates jun-N-terminal kinase, extracellular signal-regulated protein kinase, and p38 kinase in pulmonary arteries. Am J Respir Cell Mol Biol, 23(5), 593-601. (Read full article)

    Review

    1. Tsarova K, Morgan AE, Melendres-Groves L, Ibrahim MM, Ma CL, Pan IZ, Hatton ND, Beck EM, Ferrel MN, Selzman CH, Ingram D, Alamri AK, Ratcliffe MB, Wilson BD, Ryan JJ (2022). Imaging in Pulmonary Vascular Disease-Understanding Right Ventricle-Pulmonary Artery Coupling. [Review]. Compr Physiol, 12(4), 3705-3730. (Read full article)

    Case Report

    1. Pan IZ, Carey JR, Jacobs JA, Dechand J, Sessions JJ, Sorensen T, Penn BA, Mayeux JD, Hatton ND, Ryan JJ (2020). Transitioning Between Prostanoid Therapies in Pulmonary Arterial Hypertension. Front Med (Lausanne), 7, 81. (Read full article)

    Editorial

    1. Gilbertson EA, Hatton ND, Ryan JJ (2020). Point of care ultrasound: the next evolution of medical education. Ann Transl Med, 8(14), 846. (Read full article)
    2. Beck EM, Hatton ND, Ryan JJ (2019). Novel techniques for advancing our understanding of pulmonary arterial hypertension. Eur Respir J, 53(5). (Read full article)

    Letter

    1. Liou TG, Adler FR, Hatton ND (2020). The Uncertain Role of Corticosteroids in the Treatment of COVID-19. [Letter to the editor]. JAMA Intern Med, 181(1), 139-140. (Read full article)
  • News & Podcasts